Amphetamine aspartate, often encountered as a compound in certain medications, presents a fascinating case study in prodrug development. This therapeutic entity isn't the amphetamine molecule itself, but a blend where amphetamine is linked to aspartic acid. Consequently, its bioavailability profile differs from free amphetamine. The presence of asp